SEARCH

SEARCH BY CITATION

References

  • 1
    Alter M, Mast E. The epidemiology of viral hepatitis in the United States (Review). Gastroenterol Clin North Am 1994; 23:437455.MEDLINE
  • 2
    Lee WM. Hepatitis B virus infection (review). New Engl J Med 1997; 337:17331745.MEDLINE
  • 3
    Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987; 92:18441850.MEDLINE
  • 4
    Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, et al. A serologic follow-up of post-vaccinal hepatitis in the United States Army. N Engl J Med 1987; 316:965970.MEDLINE
  • 5
    Fattovich G, Gustina G, Schalm S, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. Hepatology 1995; 21:7782.MEDLINE
  • 6
    Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis (review). New Engl J Med 1997; 336:196204.MEDLINE
  • 7
    Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28:2733.MEDLINE
  • 8
    Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 15:19741976.
  • 9
    Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann Intern Med 1992; 116:97102.MEDLINE
  • 10
    Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccines. J Infect Dis 1986; 13(suppl A):3S9S.
  • 11
    Zuckerman NJ, Zuckerman AJ. Current issues in the immunization against hepatitis A and B. EiblMM, HuberC, PeterHH, WahnU, eds., Symposium in Immunology VII. Berlin: Springer. 1998;1523.
  • 12
    Carman WF, Zanetti AR, Karayannis P, Water J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325329.MEDLINE
  • 13
    Oon CJ, Tan KL, Harrison T, Zuckerman AJ. Natural history of hepatitis B surface antigen mutants in children. Lancet 348:325329.
  • 14
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, et al. Hepatitis B vaccine in medical staff of dialysis units. Efficacy and subtype cross-protection. N Engl J Med 1982; 307:14811486.MEDLINE
  • 15
    Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Eckenberg DF, Ostrow DG, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. New Engl J Med 1986; 315:209214.MEDLINE
  • 16
    Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 1991; 337:747750.MEDLINE
  • 17
    Dienstag JL, Werner BG, Polk F, Snydman DR, Craven DE, Platt R, Crumpacker CS, Quellet-Hellstrom R, Grady GF, Alper CA. Hepatitis B vaccine in health care personel: safety, immunogenicity, and indicators of efficacy. Ann Internal Med 1984; 101:3440.
  • 18
    Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. In: JSRemington, MNSwartz eds. Current clinical topics in infectious diseases. Boston: Blackwell Scientific. 1992;282308.
  • 19
    Coates RA, Halliday ML, Rankin JG, Stewart JD, Bristow NJ, Granero R, West DJ. Immunogenicity and safety of a yeast-derived recombinant DNA hepatitis B vaccine in health care workers. In: AZuckerman eds. Viral Hepatitis and Liver Disease. New York: AR Liss. 1988;10381042.
  • 20
    Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27:881886.MEDLINE
  • 21
    Keeffe EB, Krause DS. Hepatitis B vaccination of patients with chronic liver disease. Liver Transpl Surg 1998; 4:437439.MEDLINE
  • 22
    Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254:31873189.MEDLINE
  • 23
    Shaw Jr FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm Jr RR, Talley WS, Hadler SC. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7:425430.MEDLINE
  • 24
    Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: Inheritance pattern in families. J Exp Med 1992; 175:495502.MEDLINE
  • 25
    McDermott AB, Zuckerman JN, Sabin CA, Marsh SGE, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50:814.MEDLINE
  • 26
    Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998; 51:593604.MEDLINE
  • 27
    Hohler T, Meyer CU, Notghi A, Stradmann-Bellinghausen B, Schneider PM, Starke R, Zepp F, et al. The influence of major histocompatibility class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg. Hum Immunol 1998; 59:212218.MEDLINE
  • 28
    Lango-Warensjo A, Cardell K, Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998; 52:374380.MEDLINE
  • 29
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transsection of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60:646649.MEDLINE
  • 30
    Ishak K, Baptista A, Bianchi L, Caella F, De Groote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696699.MEDLINE
  • 31
    Wiese M, Porst H, Kullig M, Lafrenz G, Hauk G, Lademann M, Knoke M, et al. Geringe Zirrhoserate bei Hepatitis-C-Virus-1b-Infektion. Eine Multicenter-Studie über 20 Jahre. Dt Medizin Wschr 123:696699.
  • 32
    Olerup O, Zetterquist H. HLA-DR-typing by PCR amplification with sequence-specific primers (PCR-SSP) in two hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:225235.MEDLINE
  • 33
    Elashoff JD, Dixon WJ, Crede KM, Fotheringham N. nQuery Advisor 1.0 225235.
  • 34
    In: GWSnedecor, WGCochran eds. Statistical Methods. 7th ed. Ames IA: Iowa State University Press. 1980;149188.
  • 35
    Lou K-X, Wang L-P, Nie J, Jiang S. Is non-responsiveness to hepatitis B vaccine due to latent hepatitis B virus infection? J Infect Dis 1992; 165:777778.MEDLINE
  • 36
    Van Thiel DH. Vaccination of patients with liver disease: Who, when, and how (Editorial). Liver Transpl Surg 1998; 4:185187.MEDLINE
  • 37
    Mueller CR, Goldmann SF, Wegener S. Distribution of tissue antigens in the German normal population In: DWGiertson and PITerasaki, eds., HLA 1998, American Society for Histocompatibility and Immunogenetics. Kansas City: Lenexa. 1998;154157.
  • 38
    Schipper RF, Schreuder GMT, D'Amaro J, Oudshorn M. HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigens 1996; 48:562574.MEDLINE
  • 39
    Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209212.MEDLINE
  • 40
    Bentsi-Enchill A. Adverse events after hepatitis B vaccination. Can Med Assoc J 1992; 147:10231026.
  • 41
    Shaw FE, Graham DJ, Guess HA, Milstien JB, Johnson JM, Schatz GC, Hadler SC, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Am J Epidemiol 1988; 127:337352.MEDLINE
  • 42
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, et al. Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303:833841.MEDLINE
  • 43
    Clements ML, Miskovsky E, Davidson M, Cupps T, Kumwenda N, Sandman LA, West D, et al. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2+S antigens. J Infect Dis 1994; 170:510516.MEDLINE
  • 44
    Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in health care workers who had not responded to standard vaccine: randomised double blind dose-response study. Br Med J 1997; 314:329333.
  • 45
    Clemens R, Sänger R, Kruppenbacher J, Höbel W, Stanbury W, Bock HL, Jilg W. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule - results of a postmarketing surveillance. Vaccine 1997; 15:349352.MEDLINE
  • 46
    Kamel M, El Manialawi M, DeWolfe Miller F. Recombinant hepatitis B vaccine. Immunogenicity in presence of hepatitis C virus seropositivity. Lancet 343:349352.
  • 47
    Rosman AS, Basu P, Galvin K, Lieber Ch S. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: A randomized clinical trial. Am J Med 1997; 103:217222.MEDLINE
  • 48
    Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus and suboptimal response to hepatitis B vaccination. Ann Int Med 1988; 109:101105.
  • 49
    Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficiency. the Dialysis Vaccine Trial Study Group. N Engl J Med 1984; 311:496501.MEDLINE
  • 50
    Wood RC, MacDonald KL, White KE, Hedberg CW, Manson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270:29352939.MEDLINE
  • 51
    Zinkernagel RM. Immunology taught by viruses. Science 1996; 271:173178.MEDLINE
  • 52
    Jilg W, Schmidt M, Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988; 6:201207.MEDLINE